PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cancerinformLink to Publisher's site
 
Cancer Inform. 2010; 9: 37–38.
Published online 2010 March 3.
PMCID: PMC2865772

Expression a La Bimode

James C. Willey, Editor-in-Chief

The recently published article by Wang,1 and commented on by Ertel2 in this journal, describes development of a method, named the Bimodality Index, to objectively identify and rank meaningful and reliable bimodal patterns from large-scale gene expression datasets. This is an important step because genes with a bimodal distribution may be prime candidates to develop as molecular diagnostic tests for distinguishing clinically important groups. In their introduction, they make the point that a bimodal expression pattern may be observed when two distinct subgroups of samples are measured as one group, with each mode representing the mean expression of a gene in one of the sub-groups. Recently, it was reported that bimodal gene expression may represent another important phenomenon.

Specifically, two clinically important groups may be distinguished on the basis of a gene being unimodal in one group and bimodal in the other group. For example, certain key antioxidant, DNA repair, and transcription factor genes each display a unimodal pattern in non-lung cancer subjects but a bimodal pattern in lung cancer subjects.3 Importantly, when two groups are distinguished on the basis of unimodal vs bimodal distribution of an analyte (in this case gene expression value), biomarker development requires use of two cut-points, one on either side of the unimodal distribution. It is timely then that an improved method for separating groups on the basis of two cut-points was described recently.4

Thus, the analytical method to discover genes with bimodal expression distribution described by Wang1 and recent statistical methods that enable separation of groups on the basis of two-cut points4 are likely to accelerate both diagnostic test discovery, as well as mechanistic understanding of disease and disease risk. It is important to recognize that transcript abundance methods vary in their linear dynamic range,5 and that the ability to identify bimodal distribution of genes will depend to a significant degree on the linear dynamic range of the method used.

References

1. Wang, Jing, Wen, et al. The Bimodality Index: A Criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data. Cancer Informatics. 2009:199–216. [PMC free article] [PubMed]
2. Ertel A, et al. Bimodal Gene Expression and Biomarker Discovery. Cancer Informatics. 2010;9:11–4. [PMC free article] [PubMed]
3. Blomquist, et al. Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis. Cancer Research. 2009;69:8629–35. [PMC free article] [PubMed]
4. Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670–5. [PMC free article] [PubMed]
5. Canales RD, et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nature Biotechnology. 2006;24:1115–22. [PubMed]

Articles from Cancer Informatics are provided here courtesy of Libertas Academica